• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antipsychotic Polypharmacy in Schizophrenia: Why Not?

作者信息

Guinart Daniel, Correll Christoph U

机构信息

Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York, USA.

Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.

出版信息

J Clin Psychiatry. 2020 Apr 28;81(3):19ac13118. doi: 10.4088/JCP.19ac13118.

DOI:10.4088/JCP.19ac13118
PMID:32369690
Abstract
摘要

相似文献

1
Antipsychotic Polypharmacy in Schizophrenia: Why Not?精神分裂症中的抗精神病药物联合治疗：为何不采用？
J Clin Psychiatry. 2020 Apr 28;81(3):19ac13118. doi: 10.4088/JCP.19ac13118.
2
Antipsychotic polypharmacy: are two ever better than one?抗精神病药物联合使用：两种药物会比一种更好吗？
Am J Psychiatry. 2011 Jul;168(7):667-9. doi: 10.1176/appi.ajp.2011.11020314.
3
Monotherapy versus polypharmacy for hospitalized psychiatric patients.住院精神科患者的单药治疗与联合用药治疗
Am J Psychiatry. 2005 Mar;162(3):631-2; author reply 632-3. doi: 10.1176/appi.ajp.162.3.631-a.
4
Measuring efficacy of polypharmacy in schizophrenic inpatients.评估精神分裂症住院患者联合用药的疗效。
J Clin Psychiatry. 2004 Aug;65(8):1148; author reply 1148. doi: 10.4088/jcp.v65n0818f.
5
Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.1998 - 2000年符合医疗补助条件的精神分裂症患者中抗精神病药物联合使用的患病率、趋势及相关因素
J Clin Psychiatry. 2004 Oct;65(10):1377-88. doi: 10.4088/jcp.v65n1013.
6
Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.抗精神病药联合治疗与单药治疗与成人精神分裂症患者精神科再入院的关联。
JAMA Psychiatry. 2019 May 1;76(5):499-507. doi: 10.1001/jamapsychiatry.2018.4320.
7
Antipsychotic polypharmacy is not associated with reduced dose of individual antipsychotics in schizophrenia.在精神分裂症患者中，联合使用多种抗精神病药物与降低单一抗精神病药物的剂量并无关联。
J Clin Psychopharmacol. 2015 Apr;35(2):193-5. doi: 10.1097/JCP.0000000000000280.
8
Emerging guidelines for the use of antipsychotic polypharmacy.抗精神病药物联合使用的新兴指南。
Rev Psiquiatr Salud Ment. 2013 Jul-Sep;6(3):97-100. doi: 10.1016/j.rpsm.2013.01.001. Epub 2013 Feb 26.
9
Antipsychotic polypharmacy: never say never, but never say always.抗精神病药物联合使用：绝不说绝不，但也绝不说总是如此。
Acta Psychiatr Scand. 2012 May;125(5):349-51. doi: 10.1111/j.1600-0447.2012.01841.x.
10
Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose method.日本慢性精神分裂症患者抗精神病药物联合使用的个体化安全调整评估：抗精神病药物联合使用安全调整及高剂量法的验证
Int J Neuropsychopharmacol. 2014 Dec 11;18(5):pyu016. doi: 10.1093/ijnp/pyu016.

引用本文的文献

1
Cariprazine and clozapine: a systematic review of a promising antipsychotic combination for treatment-resistant schizophrenia.卡立哌嗪与氯氮平：对一种有前景的用于治疗难治性精神分裂症的抗精神病药物组合的系统评价
Int J Neuropsychopharmacol. 2025 Aug 1;28(8). doi: 10.1093/ijnp/pyaf053.
2
Schizophrenia and schizoaffective disorder: Length of stay and associated factors.精神分裂症和分裂情感性障碍：住院时长及相关因素。
S Afr J Psychiatr. 2024 Apr 22;30:2237. doi: 10.4102/sajpsychiatry.v30i0.2237. eCollection 2024.
3
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and China.
精神科的多药联用与体重增加：对832名因抑郁症或精神分裂症住院患者的纵向研究，以及来自欧洲、美国、南美洲和中国的3180名学生的数据。
Eur Arch Psychiatry Clin Neurosci. 2025 Jun;275(4):1001-1014. doi: 10.1007/s00406-024-01767-2. Epub 2024 Mar 10.
4
Efficacy and safety of cariprazine augmentation in patients treated with clozapine: a pilot study.卡立普嗪增效治疗氯氮平治疗患者的疗效与安全性：一项试点研究。
Ther Adv Psychopharmacol. 2022 Nov 21;12:20451253221132087. doi: 10.1177/20451253221132087. eCollection 2022.
5
Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe.青少年和青年首发及早期精神分裂症的治疗方法：欧洲德尔菲共识报告
Neuropsychiatr Dis Treat. 2022 Feb 9;18:201-219. doi: 10.2147/NDT.S345066. eCollection 2022.
6
Gender Differences of Schizophrenia Patients With and Without Depressive Symptoms in Clinical Characteristics.有和没有抑郁症状的精神分裂症患者临床特征的性别差异
Front Psychiatry. 2022 Jan 13;12:792019. doi: 10.3389/fpsyt.2021.792019. eCollection 2021.
7
Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia.详述精神医学中药物滥用的影响：320 例抑郁症或精神分裂症住院患者的纵向研究。
Eur Arch Psychiatry Clin Neurosci. 2022 Jun;272(4):603-619. doi: 10.1007/s00406-021-01358-5. Epub 2021 Nov 25.
8
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia.探索抗精神病药物联合使用治疗精神分裂症中的潜在问题。
Clin Psychopharmacol Neurosci. 2021 Nov 30;19(4):600-609. doi: 10.9758/cpn.2021.19.4.600.
9
Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?长效注射用抗精神病药物用于精神分裂症多药联合治疗方案的考量：是否应将其纳入讨论？
Clin Psychopharmacol Neurosci. 2021 Aug 31;19(3):434-448. doi: 10.9758/cpn.2021.19.3.434.
10
Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel.使用卡立普多治疗精神分裂症：从临床研究到临床实践。国际专家小组的真实世界经验与建议。
Ann Gen Psychiatry. 2020 Sep 26;19:55. doi: 10.1186/s12991-020-00305-3. eCollection 2020.